- That is the question.

A marketable therapy?

A Going Concern?

A succesful BTD?

A therapy for Covid-19 and variants?

A leader in epigenitcs?

An M&A target?

A minority shareholder takeover, ie., HEPA, et.al.?

A phase three success?

A help for diabetics?

A BP purchase?

A success?

A failure?

A proitable investment?

A succesful Covid-19 FTD Phase II therapy?

A rudderless endeavor?

A slow drift to China? (lower shareprice, HEPA ownership)

We need some answers. 

Com'n Don - 

Chicagoest